• Profile
Close

Alpha-defensins (α-Defs) in Crohn's disease: Decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility

Clinical and Experimental Immunology Dec 06, 2017

Cerrillo E, et al. - The following were the goals of this research: characterization of the concentration and utility of ileal and plasma α-defensins(α-Defs) in Crohn's disease (CD) and analysis of a potential epigenetic mechanism of α-Def expression. Findings demonstrated a correlation of the plasma α-Defs 1-3 concentrations with the degree of inflammation. In addition, plasma α-Defs 1-3 concentrations appeared to be specific biomarkers of ileal-CD at diagnosis. Data also showed permanent downregulation of ileal α-Def 5 expression by methylation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay